spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  454 Life Sciences 

 HSMN NewsFeed - 26 Feb 2018
GigaGen Announces Appointment of Jan Fredrik Simons, Ph.D., as Senior Director, Technology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 May 2011
Genetic Technologies Files New Patent Infringement Suit in USA
Biopharmaceuticals Diagnostics Oncology Litigation
 HSMN NewsFeed - 11 Jan 2010
Regulus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Aug 2008
Roche's 454 Sequencing System Used to Determine the Complete Neanderthal Mitochondrial Genome, Establishing When Humans and Neanderthals Diverged
Diagnostics
 HSMN NewsFeed - 20 Dec 2007
CuraGen Corporation Announces Appointment of Sean Cassidy as CFO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2007
CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Aug 2007
DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Biopharmaceuticals
 HSMN NewsFeed - 29 May 2007
454 Life Sciences Announces the Completion of its Acquisition by Roche
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 May 2007
CuraGen Announces Closing of 454 Life Sciences Corporation Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Mar 2007
CuraGen Announces Definitive Agreement to Sell 454 Life Sciences to Roche
Biopharmacetuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Dec 2006
CuraGen and TopoTarget Announce Expansion of Belinostat (PXD101) Clinical Trial in Cutaneous T-cell Lymphoma (CTCL)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Nov 2006
CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial of PXD101 for Myelodysplastic Syndrome
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 4 additional stories matching:
454 Life Sciences
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.